 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/17/2021 |
$104.70 |
$106.75 |
$104.15 |
$106.29 |
6.94M | | 02/18/2021 |
$105.32 |
$106.61 |
$105.21 |
$106.06 |
5.39M | | 02/19/2021 |
$106.23 |
$106.70 |
$104.91 |
$105.01 |
6.70M | | 02/22/2021 |
$104.66 |
$107.68 |
$104.23 |
$107.06 |
10.27M | | 02/23/2021 |
$106.97 |
$107.60 |
$105.96 |
$106.27 |
7.06M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on February 17, 2021, ABBV opened at $104.70, traded as high as $106.75 and as low as $104.15, and closed at $106.29. Trading volume was a total of 6.94M shares. On February 18, 2021, ABBV opened at $105.32, traded as high as $106.61 and as low as $105.21, and closed at $106.06. Trading volume was a total of 5.39M shares. On February 19, 2021, ABBV opened at $106.23, traded as high as $106.70 and as low as $104.91, and closed at $105.01. Trading volume was a total of 6.70M shares. On February 22, 2021, ABBV opened at $104.66, traded as high as $107.68 and as low as $104.23, and closed at $107.06. Trading volume was a total of 10.27M shares. On February 23, 2021, ABBV opened at $106.97, traded as high as $107.60 and as low as $105.96, and closed at $106.27. Trading volume was a total of 7.06M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
02/23/2021 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$106.27 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
398.64 |
|
| Dividends reinvested/share: |
$24.01 |
|
| Total return: |
323.64% |
|
| Average Annual Total Return: |
19.39% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$42,377.04 |
|
| Years: |
8.15 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
02/23/2021 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$106.27 |
|
| Dividends collected/share: |
$24.01 |
|
| Total return: |
270.96% |
|
| Average Annual Total Return: |
17.46% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$37,107.34 |
|
| Years: |
8.15 |
|
|
|
| Date |
Close |
| 02/17/2021 | $106.29 | | 02/18/2021 | $106.06 | | 02/19/2021 | $105.01 | | 02/22/2021 | $107.06 | | 02/23/2021 | $106.27 |
|
|
